Marc Casper, Thermo Fisher Scientific CEO (Photo by Suzanne Kreiter/The Boston Globe via Getty Images)

Ther­mo Fish­er pre­dicts rev­enue uptick in 2025 as it ex­pects head­winds to ease 

Ther­mo Fish­er told in­vestors it is ready to shut the door on 2024, an­tic­i­pat­ing biotech fund­ing to im­prove and lin­ger­ing busi­ness in­se­cu­ri­ty caused by the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA